Nektar Therapeutics

NKTR

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0000906709

SEC filings (opens in a new tab)

In the last 90 days, Nektar Therapeutics insiders filed 0 open-market purchases and 2 sales; 239 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Nektar Therapeutics changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of NKTR: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Of which not filed for Q3 2023	Q3 2023	Change
Holders	148	1	139	−8
Shares	137.9M	38.0K	143.2M	+5.39M (+3.9%)
Value	$79.3M	$22.0K	$85.3M	+$6.01M (+7.6%)

1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (16)

Institutions that held Nektar Therapeutics at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to NKTR in Q3 2023
Institution	Shares	Value	% of portfolio
Ra Capital Management, L.P.	18,700,000	$11.1M	0.22%
Marshall Wace, LLP	2,936,218	$1.76M	0.00%
Lynx1 Capital Management LP	1,766,815	$1.05M	0.70%
UBS Oconnor LLC	1,376,249	$820.2K	0.01%
Alyeska Investment Group, L.P.	1,331,720	$793.2K	0.01%
Diversified Trust Co	60,211	$35.9K	0.00%
Envestnet Portfolio Solutions, Inc.	39,626	$23.6K	0.00%
JustInvest LLC	38,584	$23.0K	0.00%
Lido Advisors, LLC	31,000	$18.5K	0.00%
Prudential Financial Inc	20,600	$12.3K	0.00%
Freestone Capital Holdings, LLC	20,000	$11.9K	0.00%
Mariner, LLC	19,036	$11.3K	0.00%
Mercer Global Advisors Inc	17,054	$10.0K	0.00%
Hall Private Wealth Advisors	10,000	$5.96K	0.00%
Provence Wealth Management Group	350	$208	0.00%
Salomon & Ludwin, LLC	46	$27	0.00%

Sold out (24)

Institutions that held Nektar Therapeutics at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of NKTR in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Sio Capital Management, LLC	6,995,381	$4.02M
Squarepoint Ops LLC	814,799	$468.7K
CWM Advisors, LLC	551,556	$317.3K
Y-Intercept (Hong Kong) Ltd	312,003	$179.5K
UBS Asset Management Americas Inc	208,662	$146.7K
Caption Management, LLC	175,411	$100.9K
Point72 Middle East FZE	137,149	$78.9K
Old Mission Capital LLC	125,544	$72.2K
Laurion Capital Management LP	84,744	$48.7K
Ergoteles LLC	37,500	$21.6K
Gladius Capital Management LP	34,143	$19.6K
Graham Capital Management, L.P.	24,095	$13.9K
Quantbot Technologies LP	20,952	$12.1K
CTC Alternative Strategies, Ltd.	16,100	$9.26K
Virtu Financial LLC	13,675	$8.00K
XTX Topco Ltd	11,826	$6.80K
Financial Advocates Investment Management	10,550	$6.07K
Supplemental Annuity Collective Trust of NJ	10,000	$5.75K
New York State Common Retirement Fund	1,293	$744
WealthPlan Investment Management, LLC	660	$380
The PNC Financial Services Group, Inc.	386	$222
Northwestern Mutual Wealth Management Co	200	$115
North Star Investment Management Corp.	125	$72
Sofos Investments, Inc.	1	–

Not filed for Q3 2023 yet (1)

Institutions that held Nektar Therapeutics at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding NKTR in Q2 2023 that haven't filed for Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
US Asset Management LLC	37,964	$22.0K